Intrinsic Value of S&P & Nasdaq Contact Us

Bausch Health Companies Inc. BHC NYSE

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
$67.78
+1093.3%
Analyst Price Target
$8.00
+40.8%

Stock Statistics — BHC

Bausch Health Companies Inc. (BHC) has a market capitalization of $2.1B and trades at $5.68. The 52-week range is 4.25-8.69.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 13.9, Earnings Per Share (EPS) of $0.41, annual revenue of $10.31B.

The stock has a beta of 0.40, operates in the Healthcare sector.

Trading Data
Current Price$5.68
52-Week Range4.25-8.69
Volume969.37K
Avg Volume (30D)2.11M
Market Cap$2.1B
Beta (1Y)0.40
Company
IPO Date1994-03-29
Employees20,700
CEOThomas J. Appio
CountryCA
ExchangeNYSE
CurrencyUSD
ISINCA0717341071
CUSIP071734107
Income (Latest Year)
Revenue$10.31B
Gross Profit$7.04B
EBITDA$3.1B
Operating Income$2.07B
Net Income$155.28M
EPS$0.41
EPS Diluted$0.41
Shares Outstanding$370.53M
Balance Sheet (Latest Year)
Total Assets$26.32B
Current Assets$6.15B
Cash & ST Investments$1.32B
Total Liabilities$25.94B
Total Debt$21.21B
Net Debt$19.88B
Total Equity$376.31M
Debt / Equity56.36
Valuation Ratios
P/E Ratio13.9
P/S Ratio0.2
P/B Ratio5.59
EV/EBITDA (approx)0.7
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message